← Leaderboards
Jeff M Szychowski
University Of Alabama At Birmingham
$5,329,448
Attributed
$16,011,966
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,011,966 · 4
By mechanism
R01$15,196,467 · 2
U01$497,332 · 1
U24$318,167 · 1
Top collaborators
- Alan Thevenet N. Tita8 shared
- Suzanne Oparil5 shared
- Paula Catherine Chandler-Laney3 shared
- Cassandra R. Newsom3 shared
- Adam W Beck1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Edward Taub$4,938,793
- Alan Thevenet N. Tita$31,628,801
- Jesse B Milby$7,957,768
- William M Geisler$14,663,241
- Joseph E Schumacher$6,282,945
Others in their field
Other Emerging Leaders on “National Heart, Lung, And Blood Institute”
- Sonia M Thomas · Research Triangle Institute$703,479,505
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ashlin Bolton · Broad Institute, Inc.$22,970,454
- Lisa Newman · Research Triangle Institute$22,725,934
- Craig Reist · Research Triangle Institute$22,725,934
Research focus
National Heart, Lung, And Blood InstituteSiteParticipantRandomizedRecommendationSafetyWomanFollow-UpChronicMedicalPrimary OutcomePremature BirthPre-EclampsiaCardiovascular SystemPregnancyFrequenciesAdverse OutcomeFetal Growth RetardationBlood PressureBirth WeightEnrollmentBloodFutureHypertension
Grant awards (10)
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,007,149
R01 · FY2025 · HL
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,485,190
R01 · FY2025 · HD
2/2 Women's Aneurysm Research: Repair Immediately Or Routine Surveillance: WARRIORS trial$318,167
U24 · FY2025 · HL · contact PI
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$1,976,808
R01 · FY2024 · HL
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,584,627
R01 · FY2024 · HD
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,046,886
R01 · FY2023 · HL
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,639,665
R01 · FY2023 · HD
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,103,237
R01 · FY2022 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,352,905
R01 · FY2021 · HL
Chronic Hypertension and Pregnancy (CHAP): Data Coordinating Center$497,332
U01 · FY2020 · HL · contact PI